| Chemical and biological terrorism | 4 | May 8, 2013 |
| TCA and Benzo toxicity | 14 | May 8, 2013 |
| CCA/BB toxicity | 18 | May 8, 2013 |
| Hematopoietic growth factors | 23 | May 8, 2013 |
| Anemia PSCH III | 39 | May 8, 2013 |
| Immunosupp - PHSC III | 40 | May 8, 2013 |
| Random HIV drugs | 6 | May 6, 2013 |
| Protease inhibitors | 15 | May 6, 2013 |
| NRTIs | 15 | May 6, 2013 |
| NNRTIs | 17 | May 6, 2013 |
| Antivirals | 10 | May 6, 2013 |
| Zoonoses and Vector bourne infections | 49 | May 6, 2013 |
| Endocarditis | 13 | May 5, 2013 |
| Joint infections | 13 | May 5, 2013 |
| Bone infections | 24 | May 5, 2013 |
| CNS infections | 61 | May 5, 2013 |
| UTIs | 29 | May 5, 2013 |
| SSTI | 40 | May 5, 2013 |
| Influenza | 17 | April 17, 2013 |
| Surgical prophylaxis | 26 | April 17, 2013 |
| IAIs | 49 | April 17, 2013 |
| STDs | 83 | April 17, 2013 |
| Nosocomial Diarrhea | 34 | April 17, 2013 |
| Acute Infectious Diarrhea | 16 | April 16, 2013 |
| Tuberculosis | 54 | April 16, 2013 |
| Nosocomial pneumonia | 34 | April 16, 2013 |
| CAP | 28 | April 16, 2013 |
| OTC block III part 2 | 11 | April 5, 2013 |
| OTC block III vitamins | 27 | April 5, 2013 |
| OTC block III | 37 | April 5, 2013 |
| Random Cancer Block III stuff | 29 | April 5, 2013 |
| MOA drugs block III part 1 | 64 | April 5, 2013 |
| Pharm III block III part 4 | 6 | April 5, 2013 |
| Pharm III block III part 3 | 31 | April 4, 2013 |
| Pharm III block III part 2 | 13 | April 4, 2013 |
| Pharm III block III part I | 25 | April 4, 2013 |
| Cancer part 1 | 15 | April 4, 2013 |
| Lipids pharmacology III | 27 | April 4, 2013 |
| PT II block I part 3 | 72 | March 26, 2013 |
| PT II block I part 2 | 76 | March 25, 2013 |
| PT II block I part I | 46 | March 25, 2013 |
| Bac1 | 41 | March 25, 2013 |
| Flouroquinolones | 16 | March 24, 2013 |
| Monobactam | 7 | March 24, 2013 |
| Carbapenams | 18 | March 24, 2013 |
| Cephalosporins | 26 | March 24, 2013 |
| Penicillins | 33 | March 24, 2013 |
| Bacteria key part 1 | 155 | March 24, 2013 |
| Gram - | 15 | March 20, 2013 |
| Gram + bacteria | 19 | March 20, 2013 |
| Basics of ID | 20 | March 20, 2013 |
| Hypertension | 24 | March 11, 2013 |
| Heart failure | 51 | March 11, 2013 |
| Myocardial Ischemia | 64 | March 11, 2013 |
| Myocardial Ischemia | 64 | March 11, 2013 |
| RAAS drugs | 26 | March 11, 2013 |
| RAAS | 31 | March 11, 2013 |
| OTC block II | 14 | March 8, 2013 |
| pharmacotherapy I cumulative | 23 | March 1, 2013 |
| Antidotes | 22 | March 1, 2013 |
| Substance abuse | 16 | February 28, 2013 |
| Managing non-pain symptoms | 8 | February 28, 2013 |
| Pain managment | 40 | February 28, 2013 |
| APAP, ASA, & opioid toxicity | 10 | February 28, 2013 |
| Intro to Toxicology | 29 | February 28, 2013 |
| OTC 54-100 | 49 | February 25, 2013 |
| Headaches | 45 | February 11, 2013 |
| Multiple Sclerosis | 58 | February 11, 2013 |
| Parkinson's Disease | 45 | February 11, 2013 |
| Alzheimer's Disease | 41 | February 11, 2013 |
| Dementia | 41 | February 11, 2013 |
| Status Epilepticus | 29 | February 11, 2013 |
| Epilepsy | 82 | February 11, 2013 |
| Movement Disorders | 23 | February 11, 2013 |
| Schizophrenia | 83 | February 11, 2013 |
| Personality disorders | 36 | February 10, 2013 |
| OTC top 54 | 54 | January 29, 2013 |
| ADHD | 23 | January 24, 2013 |
| Tics | 7 | January 24, 2013 |
| Rhett's syndrome | 5 | January 24, 2013 |
| Autism | 13 | January 24, 2013 |
| Down Syndrome | 5 | January 24, 2013 |
| Enuresis | 16 | January 24, 2013 |
| Dermatology | 29 | December 10, 2012 |
| Phosphorous and Calcium | 34 | December 9, 2012 |
| Pancreatic Hormones | 36 | December 9, 2012 |
| Advanced biopharm block III | 46 | November 8, 2012 |
| Rheumatology | 26 | November 6, 2012 |
| Block II IPPEII | 50 | October 24, 2012 |
| 5 drugs | 5 | October 24, 2012 |
| Drugs 51-100 + class | 17 | October 24, 2012 |
| Serotonin and Dopamine agonists/antagonists | 11 | October 12, 2012 |
| Pharmacology II- block 2 | 51 | October 12, 2012 |
| Top 50 Drugs/Classes | 50 | September 23, 2012 |
| Respiratory Drug Names | 25 | May 9, 2012 |
| Pharmacy Practice II final | 116 | May 9, 2012 |
| Antiinfluenza agents | 4 | May 9, 2012 |
| Anti-HBV | 7 | May 9, 2012 |
| Other antiretrovirals | 3 | May 9, 2012 |
| Antiretrovirals - PIs | 9 | May 9, 2012 |
| Antiretrovirals - NNRTIs | 5 | May 9, 2012 |
| Antiretrovirals- NRTI | 8 | May 9, 2012 |
| Cytomegalovirus (CMV) Drugs | 4 | May 9, 2012 |
| HSV/VZV Drugs | 6 | May 9, 2012 |
| 196-200 | 5 | March 16, 2012 |
| 191-195 | 5 | March 15, 2012 |
| 186-190 | 5 | March 15, 2012 |
| 181-185 | 5 | March 15, 2012 |
| 176-180 | 5 | March 15, 2012 |
| 171-175 | 5 | March 15, 2012 |
| 166-170 | 5 | March 15, 2012 |
| 161-165 | 5 | March 15, 2012 |
| 156-160 | 5 | March 15, 2012 |
| 151-155 | 5 | March 15, 2012 |
| Pharmacy practice II block 2 | 51 | March 14, 2012 |
| ADRENERGIC BASICS | 31 | March 5, 2012 |
| Adrenergic antagonists | 13 | March 5, 2012 |
| Adrenergic agonists | 18 | March 5, 2012 |
| AChEIs | 11 | March 5, 2012 |
| Adrenergic | 41 | March 5, 2012 |
| Nicotinic agonists and antagonists | 8 | March 5, 2012 |
| Muscarinic | 24 | March 5, 2012 |
| 141-150 | 10 | February 9, 2012 |
| 131-140 | 10 | February 9, 2012 |
| 121-130 | 10 | February 9, 2012 |
| 111-120 | 10 | February 9, 2012 |
| 101-110 | 10 | February 9, 2012 |
| Phys. Muscles Block III | 73 | October 31, 2011 |
| Biochem block III | 50 | October 29, 2011 |
| 51-59 | 9 | October 27, 2011 |
| 91-100 | 10 | October 27, 2011 |
| 81-90 | 10 | October 27, 2011 |
| 71-80 | 10 | October 27, 2011 |
| 60-70 | 11 | October 27, 2011 |
| Types of synovial joints | 6 | October 9, 2011 |
| Articulations | 13 | October 9, 2011 |
| Nutrients for bone | 13 | October 9, 2011 |
| Bone development/growth/and blood supply | 7 | October 9, 2011 |
| Cells of the bone | 8 | October 9, 2011 |
| Shapes of bones | 11 | October 9, 2011 |
| Classes of blood vessels | 4 | October 9, 2011 |
| Structure of vessel walls | 11 | October 9, 2011 |
| Capillaries | 4 | October 9, 2011 |
| Hepatic portal system | 7 | October 9, 2011 |
| Cardiac circuit | 10 | October 9, 2011 |
| 46-50 | 4 | September 21, 2011 |
| 35-45/100 | 10 | September 21, 2011 |
| 25-35/top100 | 11 | September 21, 2011 |
| 25-50/top 100 | 26 | September 21, 2011 |
| First 25/top 100 | 24 | September 19, 2011 |
| Calculations abbreviations | 25 | September 19, 2011 |
| Amino Acid structures- POLAR | 10 | September 10, 2011 |
| Amino Acid Structures- NONPOLAR | 10 | September 10, 2011 |
| Amino Acids | 11 | September 10, 2011 |
| Prokaryotes | 19 | September 10, 2011 |
| Cell Division | 23 | September 10, 2011 |
| Cellular life | 19 | September 10, 2011 |
| Inflammatory drugs | 14 | September 9, 2011 |
| Cells of the immune system | 16 | September 8, 2011 |
| Complement protiens | 5 | September 7, 2011 |
| Immunoglobulins | 5 | September 7, 2011 |
| Phagocytic response to infection | 14 | September 7, 2011 |
| Barriers | 18 | September 7, 2011 |
| The integumentary system | 85 | September 6, 2011 |
| Ch1 Organ System over view | 32 | September 6, 2011 |
| Cells of the immune system | 23 | September 5, 2011 |
| Complement II | 7 | September 5, 2011 |
| Complement I | 12 | September 5, 2011 |
| Immunoglobulins part II | 13 | September 5, 2011 |
| Immunoglobulins | 12 | September 5, 2011 |
| Antigens | 14 | September 5, 2011 |
| Conversions | 18 | August 31, 2011 |
| tissues-physiology part II | 47 | August 30, 2011 |
| Tissues-Physiology part I | 85 | August 30, 2011 |